Schonfeld Strategic Advisors »

Keros Therapeutics shares owned by Schonfeld Strategic Advisors

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Schonfeld Strategic Advisors from 13F filings

Historical chart of Schonfeld Strategic Advisors investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Schonfeld Strategic Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Schonfeld Strategic Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $3.8M 95k 39.76
2023-09-30 $2.5M 78k 31.88
2023-06-30 $3.5M 87k 40.18
2023-03-31 $2.4M 57k 42.70
2022-12-31 $1.9M 40k 48.02
2022-03-31 $984k 18k 54.37
2021-12-31 $939k 16k 58.53
2021-03-31 $1.0M 17k 61.54